STAGE II HEPATOCELLULAR CARCINOMA AJCC V8
Clinical trials for STAGE II HEPATOCELLULAR CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II HEPATOCELLULAR CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II HEPATOCELLULAR CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug combo aims to stop liver cancer return after surgery
Disease control OngoingThis study tests whether giving two drugs (atezolizumab and bevacizumab) before surgery can help prevent liver cancer from coming back. The drugs work by boosting the immune system to attack cancer and blocking blood supply to tumors. 16 adults with removable liver cancer took pa…
Matched conditions: STAGE II HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New drug cocktail shows promise for tough liver cancers
Disease control OngoingThis early-phase trial tests whether combining regorafenib (a targeted therapy) with durvalumab (an immunotherapy) can shrink tumors in 4 adults with high-risk liver cancer before surgery. The goal is to see if the treatment reduces tumor size enough to improve surgical outcomes.…
Matched conditions: STAGE II HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC